Home › Diffuse Scleroderma › Texas › Dallas
Diffuse Scleroderma clinical trials in Dallas, TX
3 studies for Diffuse Scleroderma are looking for participants at sites in and around Dallas (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)
RecruitingPhase 1/2
- Nkarta Investigational Site, Dallas
EncompaSSc: Evaluation of MTX-474 in Participants With Diffuse Cutaneous Systemic Sclerosis (dcSSc)
RecruitingPhase 2
- Baylor Scott & White Research Institute, Dallas
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
RecruitingPhase 2
- Artiva Investigational Site Red Oak, Red Oak · 18 mi away
Diffuse Scleroderma trials in other cities
- New York City, NY7 studies
- Durham, NC6 studies
- Los Angeles, CA6 studies
- Ann Arbor, MI6 studies
- Boston, MA5 studies
- Baltimore, MD5 studies
- Chicago, IL5 studies
- Kansas City, KS4 studies
- Philadelphia, PA4 studies
- Pittsburgh, PA4 studies
- Charleston, SC3 studies
- Houston, TX3 studies
Other studies in Dallas
- Breast Cancer54 studies
- Non-Small Cell Lung Cancer53 studies
- Metastatic Cancer44 studies
- Heart Failure42 studies
- Cancer (all types)40 studies
- Prostate Cancer39 studies
- Colorectal Cancer34 studies
- Obesity33 studies
- Ovarian Cancer31 studies
- Bladder Cancer27 studies
- Lung Cancer26 studies
- Endometrial Cancer25 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.